FDA Authorizes Pfizer-BioNTech COVID Vaccine for Emergency Use Authorization (EUA) in adolescents for fight against pandemic


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
FDA is working towards the safety of adolescents and the children who are innocent minds and need special care towards pandemics. FDA authorizes Pfizer-BioNTech COVID Vaccine for Emergency Use Authorization (EUA) for adolescents.

The global hunt for COVID 19 vaccine begins for adolescents and kids. A lagging start in the case of COVID 19 on children has some pediatricians worried which leads to wanting more shots for young children in time for the next school year. Older kids and adolescents are more vulnerable to coronavirus, but ending the pandemic will require vaccinating the children as soon as possible. 

COVID vaccine for children below the age of 12 years 

Last week, Pfizer received permission to test its vaccine in kids as young as 12 only for a handful of attempts around the world. Multiple vaccine candidates are in the final stage of studies for many adolescents. Scientists and researchers are hopeful that the next few months will bring evidence of at least some of them which are safe, effective, and can be used for widespread use. Generally, when the first shots arrive they are unlikely to be recommended for the children. Vaccines can be given to youngsters unless they have been tested in a particular age group. This is a major hurdle in efforts to reopen the school and resume more activities. 

Study in regards to COVID vaccine for children 

Children represent about 10 % of COVID19 cases documented worldwide. Children are far less likely to get affected by the serious illness of coronavirus. About 120 children have died in the USA alone according to the American Academy of Pediatrics. This average is about the general value of how many children die in the USA by flu. A smaller number of children have developed a serious inflammatory condition linked to the coronavirus. COVID 19 impact on children is greater than some other diseases that require routine pediatric vaccinations. 

Efficacy for pediatric vaccines 

Globally pediatric studies are emerging slowly. Many studies have come up for children of age 3-12 years. Testing a lower dosage of the vaccine in children of smaller age groups will be a better idea. Immunizing the adolescents and potentially moving down into yonder children is going to be effective for children. It is important to keep an eye on coronavirus infections among children and monitor them closely. For these reasons, the schools have been kept close so that they don't bring infection home to parents and grandparents. 

FDA statement from Acting Commissioner  Janet Woodcock MD

It makes sense to start pediatric testing in teenagers and gradually work done in an age. Adolescents usually received adult-sized doses of other vaccines. The FDA's expansion of emergency use authorization for the Pfizier-BioNTech COVID 19 vaccine to include adolescents 12- 15 years of age is one of the most important steps to fight against the COVID 19 pandemic. Acting FDA Commissioner Janet Woodcock MD informed, “Today’s action allows for a younger population to be protected from COVID19, bringing us closer to returning to a sense of normalcy and to ending the pandemic.” She further gave reassurance to parents and guardians about the agency step to look into the rigorous and thorough review of all available data. 

Report by Center of Disease Control Prevention 

From March 1, 2020 - April 30, 2021, approximately 1.5 million COVID 19 cases have come into the light among the individuals from age of 11 -17 years. This has been reported by the Center for Disease Control and Prevention (CDC). Children and adolescents have known to be reported milder symptoms as compared to adults. A low dosage of the COVID vaccine for children should be effectively provided the efficacy is taken care of.




Tags : #FDA #Pfizer-BioNTechCOVIDVaccine #EUA #myhealth #COVIDvaccine #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026